Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature

Currently, there are a few systemic treatment options for patients with metastatic colorectal cancer (mCRC). Targeted therapy used in this setting includes the use of monoclonal antibodies, such as cetuximab or panitumumab, directed against epidermal growth factor receptor. The aim of the present st...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: STREB, JOANNA, PÜSKÜLLÜOĞLU, MIROSLAWA, GLANOWSKA, IZABELA, OCHENDUSZKO, SEBASTIAN, KONOPKA, KAMIL, ŁUPKOWSKI, RADOSLAW, MICHALOWSKA-KACZMARCZYK, ANNA, BOCHENEK-CIBOR, JUSTYNA, MAJKA, MARCIN, KRZEMIENIECKI, KRZYSZTOF
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2015
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4665193/
https://ncbi.nlm.nih.gov/pubmed/26788202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3800
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky